Microinvasive squamous cell carcinoma arising in discoid lupus erythematosus lesions successfully treated with imiquimod 5% cream
dc.contributor.author | Ermertcan A.T. | |
dc.contributor.author | Gencoglan G. | |
dc.contributor.author | Eskiizmir G. | |
dc.contributor.author | Temiz P. | |
dc.date.accessioned | 2024-07-22T08:19:09Z | |
dc.date.available | 2024-07-22T08:19:09Z | |
dc.date.issued | 2013 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.DOI-ID | 10.4103/0378-6323.104686 | |
dc.identifier.issn | 09733922 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17555 | |
dc.language.iso | English | |
dc.rights | All Open Access; Gold Open Access | |
dc.subject | Administration, Cutaneous | |
dc.subject | Aminoquinolines | |
dc.subject | Antineoplastic Agents | |
dc.subject | Carcinoma, Squamous Cell | |
dc.subject | Ear | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Lip | |
dc.subject | Lupus Erythematosus, Discoid | |
dc.subject | Middle Aged | |
dc.subject | Treatment Outcome | |
dc.subject | imiquimod | |
dc.subject | sunscreen | |
dc.subject | adult | |
dc.subject | application site burning | |
dc.subject | application site irritation | |
dc.subject | cancer diagnosis | |
dc.subject | cancer recurrence | |
dc.subject | cancer size | |
dc.subject | case report | |
dc.subject | cell vacuole | |
dc.subject | debridement | |
dc.subject | discoid lupus erythematosus | |
dc.subject | disease duration | |
dc.subject | elastosis | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | invasive carcinoma | |
dc.subject | letter | |
dc.subject | medical history | |
dc.subject | outcome assessment | |
dc.subject | squamous cell carcinoma | |
dc.subject | treatment duration | |
dc.subject | tumor invasion | |
dc.subject | wound healing impairment | |
dc.title | Microinvasive squamous cell carcinoma arising in discoid lupus erythematosus lesions successfully treated with imiquimod 5% cream | |
dc.type | Letter |